Mengis Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,258
Closed -$211K 166
2022
Q2
$211K Sell
6,258
-1,329
-18% -$46.5K 0.05% 159
2022
Q1
$265K Sell
7,587
-1,916
-20% -$65.5K 0.05% 159
2021
Q4
$289K Sell
9,503
-4,562
-32% -$149K 0.05% 157
2021
Q3
$461K Sell
14,065
-175
-1% -$5.6K 0.1% 135
2021
Q2
$430K Buy
+14,240
New +$469K 0.09% 139

Other funds holding OGN

Mengis Capital Management's OGN Position: Q3 2022 in Review

Mengis Capital Management sold out of Organon & Co (OGN) in Q3 2022, closing a stake of 6,258 shares — an estimated $211K sold.

Mengis Capital Management first reported a position in OGN in Q2 2021 and held it in 5 quarters. The position peaked at $461K in Q3 2021. 791 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

  • Mengis Capital Management reported no remaining Organon & Co position as of Q3 2022 after selling out during the quarter.
  • Mengis Capital Management sold 6,258 Organon & Co shares in Q3 2022, an estimated $211K.
  • Mengis Capital Management first reported a position in Organon & Co in Q2 2021 and held it in 5 quarters.
  • Mengis Capital Management's Organon & Co position peaked at $461K in Q3 2021.
  • 791 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on Mengis Capital Management's 13F filing for Q3 2022, filed 4 Nov 2022.